The study conducted by Man and colleagues revealed that Gankyrin is highly expressed in lung cancer cell lines and lung cancer tissues, and mediates phosphatase and tensin homolog (PTEN) degradation through an interaction with Rho GDP-dissociation inhibitor (RhoGDI). Here, RHO is linked to lung carcinoma.